S&P 500   3,304.01 (+0.29%)
DOW   26,806.03 (+0.53%)
QQQ   269.45 (+0.03%)
AAPL   437.32 (+0.36%)
MSFT   212.16 (-2.02%)
FB   249.22 (-1.09%)
GOOGL   1,471.09 (-0.79%)
AMZN   3,123.78 (+0.38%)
NVDA   447.25 (+1.55%)
CGC   19.37 (+1.63%)
BABA   261.92 (+1.54%)
TSLA   1,478.50 (-0.44%)
MU   51.18 (+1.57%)
GE   6.14 (+0.49%)
AMD   84.82 (+9.21%)
T   30.01 (+1.32%)
F   6.85 (+2.39%)
ACB   10.73 (+2.98%)
GILD   70.68 (-1.46%)
NFLX   508.92 (+2.07%)
DIS   117.45 (+0.95%)
BAC   24.95 (-0.16%)
BA   164.90 (+1.62%)
S&P 500   3,304.01 (+0.29%)
DOW   26,806.03 (+0.53%)
QQQ   269.45 (+0.03%)
AAPL   437.32 (+0.36%)
MSFT   212.16 (-2.02%)
FB   249.22 (-1.09%)
GOOGL   1,471.09 (-0.79%)
AMZN   3,123.78 (+0.38%)
NVDA   447.25 (+1.55%)
CGC   19.37 (+1.63%)
BABA   261.92 (+1.54%)
TSLA   1,478.50 (-0.44%)
MU   51.18 (+1.57%)
GE   6.14 (+0.49%)
AMD   84.82 (+9.21%)
T   30.01 (+1.32%)
F   6.85 (+2.39%)
ACB   10.73 (+2.98%)
GILD   70.68 (-1.46%)
NFLX   508.92 (+2.07%)
DIS   117.45 (+0.95%)
BAC   24.95 (-0.16%)
BA   164.90 (+1.62%)
S&P 500   3,304.01 (+0.29%)
DOW   26,806.03 (+0.53%)
QQQ   269.45 (+0.03%)
AAPL   437.32 (+0.36%)
MSFT   212.16 (-2.02%)
FB   249.22 (-1.09%)
GOOGL   1,471.09 (-0.79%)
AMZN   3,123.78 (+0.38%)
NVDA   447.25 (+1.55%)
CGC   19.37 (+1.63%)
BABA   261.92 (+1.54%)
TSLA   1,478.50 (-0.44%)
MU   51.18 (+1.57%)
GE   6.14 (+0.49%)
AMD   84.82 (+9.21%)
T   30.01 (+1.32%)
F   6.85 (+2.39%)
ACB   10.73 (+2.98%)
GILD   70.68 (-1.46%)
NFLX   508.92 (+2.07%)
DIS   117.45 (+0.95%)
BAC   24.95 (-0.16%)
BA   164.90 (+1.62%)
S&P 500   3,304.01 (+0.29%)
DOW   26,806.03 (+0.53%)
QQQ   269.45 (+0.03%)
AAPL   437.32 (+0.36%)
MSFT   212.16 (-2.02%)
FB   249.22 (-1.09%)
GOOGL   1,471.09 (-0.79%)
AMZN   3,123.78 (+0.38%)
NVDA   447.25 (+1.55%)
CGC   19.37 (+1.63%)
BABA   261.92 (+1.54%)
TSLA   1,478.50 (-0.44%)
MU   51.18 (+1.57%)
GE   6.14 (+0.49%)
AMD   84.82 (+9.21%)
T   30.01 (+1.32%)
F   6.85 (+2.39%)
ACB   10.73 (+2.98%)
GILD   70.68 (-1.46%)
NFLX   508.92 (+2.07%)
DIS   117.45 (+0.95%)
BAC   24.95 (-0.16%)
BA   164.90 (+1.62%)
Log in

NASDAQ:GBTGlobal Blood Therapeutics Price Target & Analyst Ratings

$68.69
-1.79 (-2.54 %)
(As of 08/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$68.15
Now: $68.69
$69.76
50-Day Range
$62.66
MA: $68.87
$74.49
52-Week Range
$39.95
Now: $68.69
$87.54
Volume16,841 shs
Average Volume543,842 shs
Market Capitalization$4.19 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.87

Analyst Ratings

Global Blood Therapeutics (NASDAQ:GBT) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
21 Wall Street analysts have issued ratings and price targets for Global Blood Therapeutics in the last 12 months. Their average twelve-month price target is $105.65, suggesting that the stock has a possible upside of 53.81%. The high price target for GBT is $150.00 and the low price target for GBT is $60.00. There are currently 4 hold ratings and 17 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.812.762.692.69
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
17 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $105.65$105.00$97.40$95.60
Price Target Upside: 53.81% upside57.89% upside25.58% upside40.63% upside

Global Blood Therapeutics (NASDAQ:GBT) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Global Blood Therapeutics (NASDAQ:GBT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/29/2020Piper SandlerReiterated RatingBuy$120.00Low
7/20/2020Roth CapitalInitiated CoverageBuy$129.00Low
7/13/2020BofA SecuritiesInitiated CoverageBuy$92.00High
7/13/2020Bank of AmericaInitiated CoverageBuy$92.00 ➝ $92.00High
7/1/2020Goldman Sachs GroupUpgradeNeutral ➝ Buy$91.00 ➝ $103.00High
6/25/2020HC WainwrightReiterated RatingBuy$150.00Low
6/25/2020Canaccord GenuityReiterated RatingHoldLow
6/23/2020WedbushReiterated RatingBuy$145.00High
6/15/2020OppenheimerReiterated RatingBuy$101.00High
6/12/2020Wells Fargo & CoReiterated RatingBuyHigh
5/7/2020Cantor FitzgeraldBoost Price Target$105.00 ➝ $130.00Low
5/7/2020NomuraReiterated RatingBuy$112.00Low
5/7/2020Morgan StanleyBoost Price TargetEqual Weight$70.00 ➝ $75.00High
4/27/2020Stifel NicolausInitiated CoverageBuy$112.00Low
1/31/2020SunTrust BanksDowngradeBuy ➝ Hold$110.00 ➝ $75.00High
12/23/2019Piper Jaffray CompaniesReiterated RatingBuy$120.00N/A
12/18/2019William BlairReiterated RatingBuyHigh
12/17/2019JPMorgan Chase & Co.Boost Price TargetEqual Weight$58.00 ➝ $79.00Low
11/26/2019Nomura SecuritiesBoost Price TargetBuy$109.00 ➝ $112.00High
11/26/2019Janney Montgomery ScottBoost Price TargetBuy$75.00 ➝ $90.00High
10/9/2019CowenSet Price TargetBuy$83.00Low
2/22/2019GuggenheimInitiated CoverageBuy$75.00Low
4/26/2018Needham & Company LLCReiterated RatingBuy$70.00High
(Data available from 8/4/2018 forward)
This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.